Anne McTiernan, MD, PhD
Public Health Sciences Division
University of Washington
Fred Hutchinson Cancer Research Center
Characterizing the effect of exercise and weight loss on markers of breast cancer risk in women of all body sizes and fitness levels.
Physical activity is associated with improved survival of breast cancer at any age, which may be due, in part, to its effects on weight. Dr. McTiernan and others have shown that weight loss has significant, long-term effects on biological factors linked to breast cancer risk. However, exercise may reduce risk in other ways beyond weight loss. Dr. McTiernan's work suggests that some of its biological effects are greatest in the hours after a workout. She is currently studying the acute effects of exercise on biomarkers of breast cancer risk in patients of varying body types and fitness levels, the results of which may be informative in assessing risk and developing prevention interventions. She and her team launched the first-ever clinical trial to test the immediate effects of exercise on markers related to breast cancer. If the markers are significantly altered, it could help support guidelines for daily exercise for breast cancer prevention-and it may indicate that exercise even without weight loss is beneficial.
Dr. McTiernan and her team launched the ACute Effects of Exercise in Women (ACE) trial. Forty out of 100 patients enrolled in the study so thus far and the team collected muscle biopsies pre-and post-exercise for analysis. They are also measuring markers related to inflammation and angiogenesis—both of which contribute to cancer progression—and will determine whether the effects differ between normal-weight and overweight/obese patients.
In the coming year the team will complete the ACE trial, and they have added a test to measure irisin—a hormone released by muscle and fat tissue that may have anti-tumor properties—in stored blood once ACE accrual is complete. In addition, a new analysis will be underway to test the separate and combined effects of dietary weight loss and moderate exercise in 439 women with overweight/obesity, on irisin levels in stored blood from a completed weight loss trial.
“If not for BCRF, we could not have discovered ways that exercise and weight loss can impact biology and help prevent breast cancer.” – Dr. McTiernan
Anne McTiernan, MD, PhD is a Full Member at the Fred Hutchinson Cancer Research Center and Research Professor at the University of Washington Schools of Medicine and Public Health in Seattle. Dr. McTiernan’s research focuses on identifying ways to prevent new or recurrent breast cancer with physical activity, obesity prevention and treatment, and chemoprevention. She is Principal Investigator of several clinical trials and cohort studies investigating the effects of exercise, diet, weight, hormones, and chemoprevention agents on breast cancer incidence and prognosis. She was PI of the National Cancer Institute funded Seattle Transdisciplinary Research on Energetics and Cancer program that investigated obesity prevention and mechanisms linking overweight, obesity and sedentary lifestyles with breast cancer.
Dr. McTiernan is an elected Fellow in the American College of Sports Medicine, the Obesity Society, and the American College of Epidemiology. She has published more than 400 scientific manuscripts in major medical journals and is lead author of the book, Breast Fitness (St. Martin’s Press, 2000). She is editor of two academic texts: Cancer Prevention and Management through Exercise and Weight Control (CRC Press LLL, 2005) and Physical Activity, Dietary Calorie Restriction, and Cancer (Springer; 2010). Her memoir, Starved: A Nutrition Doctor’s Journey from Empty to Full (Central Recovery Press) was published in 2016. She has served on national and international health advisory boards and working groups including the International Agency for Research on Cancer, the American Cancer Society, the US Department of Health and Human Services Physical Activity Guidelines Advisory Committees, the World Cancer Research Foundation, and the Komen for the Cure Scientific Advisory Council.
When you give to BCRF, you're funding critical hours in the lab. More time for research means longer, healthier lives for the ones we love.